Drawing for AQUARIUZ

USPTO serial 79274233

AQUARIUZ

Reviewed by CopyMark Law Group

Reg. 6213527Status 700Renewal
Filing date
Status date
Registration date
Dec 8, 2020
Examiner
O'BRIEN, ELIZABETH A
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with AQUARIUZ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*

Plus Government fees of $975

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Julie Reitz

Julie Reitz Honigman LLP34900 Woodward Avenue, Suite 101Bloomfield Hills, MI 48304UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010Surgical and medical apparatus and instruments for use in ophthalmological and otologic surgery; diagnostic apparatus for medical use, namely, diagnostic apparatus for the detection of optical medical conditions; medical apparatus and instruments for use in ophthalmology and otology procedures; apparatus and instruments for medical use for ophthalmological and otologic diagnosis and surgery; lasers for medical use; ophthalmological and medical apparatus and instruments, namely, optometric instruments for locating the optical center of ophthalmic lenses; instruments for ophthalmic laser surgery, medical apparatus for therapeutic use in the nature of therapeutic eye hydration goggles for the treatment of dry eyes, electro-medical apparatus and their parts in the nature of medical imaging devices for eyes, medical apparatus for analysis of opthalmological conditions, apparatus for monitoring vital signs of patients as well as measuring and monitoring apparatus for medical use in the nature of a device for measuring arterial blood flow in the eye; eye testing apparatus for medical use; ocular and intra-ocular prostheses for surgical implantation, apparatus and instruments for ophthalmological surgery, surgical suture material; all the aforementioned goods only used in the field of ophthalmologyACTIVE—
042Scientific and industrial research services and development relating to medical technology, advisory services relating to scientific and industrial research; scientific and industrial research and development services; scientific and technological services, namely, scientific analysis and research services in the field of optometry; design and development of computers and software; computer system design; conversion of data or documents from physical to electronic media; duplication of computer programsACTIVE—
044Medical services; medical analysis services relating to the management of individuals; health services, namely, optometry services; medical treatment of eye disorders by means of a surgical procedure as well consulting services relating thereto; medical treatment, namely, refractive treatment using a femtosecond surgical laser; medical treatment, namely, refractive ablation and corneal graftingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 8, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 18, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 10, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 28, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 8, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 8, 2021FIMPFINAL DISPOSITION PROCESSED—
Mar 8, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 8, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 22, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 22, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 2, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 18, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 14, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 14, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 14, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 13, 2020RFNTREFUSAL PROCESSED BY IB—
Feb 27, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 27, 2020RFRRREFUSAL PROCESSED BY MPU—
Feb 5, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 4, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 4, 2020DOCKASSIGNED TO EXAMINER—
Dec 24, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 20, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 19, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance